Markovič, T.; Podgornik, H.; Avsec, D.; Nabergoj, S.; Mlinarič-Raščan, I.
The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies. Int. J. Mol. Sci. 2022, 23, 1599.
https://doi.org/10.3390/ijms23031599
AMA Style
Markovič T, Podgornik H, Avsec D, Nabergoj S, Mlinarič-Raščan I.
The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies. International Journal of Molecular Sciences. 2022; 23(3):1599.
https://doi.org/10.3390/ijms23031599
Chicago/Turabian Style
Markovič, Tijana, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, and Irena Mlinarič-Raščan.
2022. "The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies" International Journal of Molecular Sciences 23, no. 3: 1599.
https://doi.org/10.3390/ijms23031599
APA Style
Markovič, T., Podgornik, H., Avsec, D., Nabergoj, S., & Mlinarič-Raščan, I.
(2022). The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies. International Journal of Molecular Sciences, 23(3), 1599.
https://doi.org/10.3390/ijms23031599